Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.

@article{Capitanio2009PopulationbasedSO,
  title={Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.},
  author={Umberto Capitanio and Claudio Jeldres and Paul Perrotte and Hendrik Isbarn and Maxime Crepel and Vincent Cloutier and Sara Baillargeon-Gagn{\'e} and Shahrokh F Shariat and Alain Duclos and Philippe Arjane and Hugues Widmer and Fred Saad and Francesco Montorsi and Pierre I. Karakiewicz},
  journal={Urology},
  year={2009},
  volume={74 2},
  pages={373-7}
}
OBJECTIVES To determine whether retroperitoneal lymphadenectomy (RPLND) perioperative mortality (PM) rates reported from a center of excellence (Indiana University: 0% for primary and 0.8% for postchemotherapy RPLND) are applicable to institutions at large. METHODS We used the data from 882 assessable patients with nonseminomatous testicular germ cell tumor treated with RPLND from 1988 to 1997 accessed from the Surveillance, Epidemiology, and End Results (SEER) database. These data did not… CONTINUE READING